OSIR

Osiris Therapeutics, Inc. News Headlines

$14.48
*  
0.65
4.7%
Get OSIR Alerts
*Delayed - data as of Dec. 18, 2014  -  Find a broker to begin trading OSIR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OSIR After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Celgene Reaches 52-Week High - Analyst Blog
4/2/2013 9:08:11 AM - Zacks.com


Gilead's HCV Study to Continue - Analyst Blog
4/1/2013 4:05:01 PM - Zacks.com


Bad News for Alexion, Shares Down - Analyst Blog
4/1/2013 3:07:41 PM - Zacks.com


Acorda Reports Data on Epilepsy Drug - Analyst Blog
3/26/2013 3:27:57 PM - Zacks.com


Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors
3/26/2013 9:01:00 AM - Seeking Alpha


SGEN Seeks Adcetris Label Expansion - Analyst Blog
3/19/2013 6:15:01 PM - Zacks.com


AstraZeneca to Revamp R&D Structure - Analyst Blog
3/19/2013 4:47:17 PM - Zacks.com


Cell Therapy Leader Stephen Potter Talks Osiris, NeoStem And The Industry Itself
3/19/2013 9:15:00 AM - Seeking Alpha


Theravance Inks Deal for Vibativ - Analyst Blog
3/18/2013 3:44:02 PM - Zacks.com


BioLineRx to Initiate HCV Study - Analyst Blog
3/15/2013 3:45:23 PM - Zacks.com


Alexion Pharma Upgraded to Outperform - Analyst Blog
3/15/2013 1:48:02 PM - Zacks.com


The Stem Cell Revolution Can Jump Start Your Portfolio: Jason Kolbert
3/15/2013 11:20:00 AM - Seeking Alpha


Peregrine Reports Narrower Loss - Analyst Blog
3/13/2013 5:14:18 PM - Zacks.com


Biogen Files Hemophilia B Application - Analyst Blog
3/13/2013 3:09:18 PM - Zacks.com


Major Setback for Aeterna Zentaris - Analyst Blog
3/12/2013 6:13:03 PM - Zacks.com


Osiris Wows The Market With Stellar Earnings Report
3/8/2013 4:54:00 PM - Seeking Alpha


Acorda Presents GGF2 Data - Analyst Blog
3/8/2013 4:15:01 PM - Zacks.com


Narrower-Than-Expected Loss at OSIR - Analyst Blog
3/7/2013 8:30:01 AM - Zacks.com


Osiris Therapeutics: A Few Things To Consider As Earnings Trump Estimates
3/7/2013 1:44:00 AM - Seeking Alpha


Market Wrap for Wednesday, March 6: Stocks Close Mixed as Euro Tests Key Support Level Ahead of ECB Meeting
3/6/2013 4:09:25 PM - Benzinga


2012 Stem Cell Standouts And The Outlook For 2013
2/28/2013 2:15:00 PM - Seeking Alpha


Acute Radiation Syndrome, Are We Prepared And Who Is Best Preparing Us?
2/27/2013 9:40:00 AM - Seeking Alpha


Osiris Therapeutics On The Brink: Products Failing To Deliver
2/20/2013 4:12:00 PM - Seeking Alpha


2 Regenerative Medicine Plays For 2013
2/13/2013 3:36:00 PM - Seeking Alpha


Stem Cell Therapy Companies: Underappreciated Outperformers
1/29/2013 8:40:00 AM - Seeking Alpha